Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HDAC Inhibitor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00437957
What this trial is testing

Phase I Study of Temozolomide, Valproic Acid and Radiation Therapy in Patients With Brain Metastases

Who this might be right for
Brain Metastases
H. Lee Moffitt Cancer Center and Research Institute 10
Testing effectiveness (Phase 2)Study completedNCT02513901
What this trial is testing

Chidamide in Combination With Antiretroviral Therapy for Eradication of the Latent HIV-1 Reservoir

Who this might be right for
Chronic HIV Infections
Tang-Du Hospital 13
Testing effectiveness (Phase 2)Ended earlyNCT00490776
What this trial is testing

Study of Oral LBH589 in Adult Participants With Refractory/Resistant Cutaneous T-Cell Lymphoma (CTCL)

Who this might be right for
Cutaneous T-Cell Lymphoma
Novartis Pharmaceuticals 9
Early research (Phase 1)Study completedNCT01273155
What this trial is testing

Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction

Who this might be right for
NeoplasmsLymphomas
National Cancer Institute (NCI) 72
Not applicableNo Longer AvailableNCT02204553
What this trial is testing

Expanded Treatment Prot of Panobinostat in Combo w/ Bortez and Dex in Pts w/ Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT00699296
What this trial is testing

Study of Oral LBH589 in Patients With Cutaneous T-cell Lymphoma and Adult T-cell Leukemia/Lymphoma

Who this might be right for
Cutaneous T-Cell LymphomaLeukemia-Lymphoma, Adult T-Cell
Novartis Pharmaceuticals 4
Testing effectiveness (Phase 2)Ended earlyNCT04651127
What this trial is testing

Anti-PD-1 Antibody Combined With Histone Deacetylase Inhibitor in Patients With Advanced Cervical Cancer

Who this might be right for
Cervical CancerCervix CancerCervix Neoplasm
Sun Yat-sen University 5
Testing effectiveness (Phase 2)WithdrawnNCT02115594
What this trial is testing

Phase 2 Study of Fulvestrant With and Without Entinostat in Postmenopausal Women With ER+ Advanced Breast Cancer

Who this might be right for
Breast Cancer
Syndax Pharmaceuticals
Large-scale testing (Phase 3)UnknownNCT03564470
What this trial is testing

Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph-like ALL

Who this might be right for
LeukemiaLeukemia, AcuteLeukemia, Lymphoblastic+1 more
Nanfang Hospital, Southern Medical University 120
Testing effectiveness (Phase 2)Study completedNCT01680094
What this trial is testing

Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART

Who this might be right for
HIV Infection
University of Aarhus 15
Testing effectiveness (Phase 2)Ended earlyNCT00723203
What this trial is testing

Panobinostat in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Who this might be right for
Leukemia
City of Hope Medical Center 16
Early research (Phase 1)Ended earlyNCT00676728
What this trial is testing

The Histone-deacetylase Inhibitor JNJ-26481585 in Patients With Advanced or Refractory Leukemia or Myelodysplastic Syndrome

Who this might be right for
Advanced or Refractory LeukemiaMyelodysplastic Syndromes
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 10
Testing effectiveness (Phase 2)Ended earlyNCT01090973
What this trial is testing

Oral LBH589 in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL)

Who this might be right for
Non-Hodgkin's Lymphoma
H. Lee Moffitt Cancer Center and Research Institute 1
Testing effectiveness (Phase 2)Ended earlyNCT00383565
What this trial is testing

FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Recurrent Adult Diffuse Large Cell LymphomaRecurrent Mantle Cell Lymphoma
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Study completedNCT00212316
What this trial is testing

Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD)

Who this might be right for
Huntington's Disease
University of Rochester 60
Testing effectiveness (Phase 2)Study completedNCT01238692
What this trial is testing

A Phase II Study of Oral Panobinostat (LBH589) and Rituximab to Treat Diffuse Large B Cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B Cell Lymphoma
Sarit Assouline 42
Testing effectiveness (Phase 2)Study completedNCT00077194
What this trial is testing

FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
National Cancer Institute (NCI) 35
Early research (Phase 1)Study completedNCT02909452
What this trial is testing

Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors

Who this might be right for
NeoplasmsNeoplasms, Glandular and EpithelialNeoplasms by Histologic Type+11 more
Syndax Pharmaceuticals 30
Early research (Phase 1)Active Not RecruitingNCT01087554
What this trial is testing

Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer

Who this might be right for
Advanced Cancer
M.D. Anderson Cancer Center 249
Early research (Phase 1)Study completedNCT01463046
What this trial is testing

Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaAdvanced Myelodysplastic Syndrome
University of California, San Francisco 29
Next Page